C0012022||Diazoxide
C0162772||reactive oxygen species
C1096176||mitochondrial damage
C0243095||anti-hypertrophic effects
C1383860||cardiac hypertrophy
C0446987||wall
C0205400||thickening
C0729936||chamber
C0020564||enlargement
C0018787||heart
C0184511||improve
C0178784||organ
C1258017||contractile function
C0026237||mitochondria
C0242606||oxidative stress
C0764439||Mitochondrial ATP-sensitive K(+) channels
C0764439||mitoKATP
C0443264||modulate
C0030012||redox status
C0007634||cell
C0018787||cardiac
C0764439||mitoKATP
C1882151||opening
C0012022||diazoxide
C0022245||isoproterenol
C1383860||cardiac hypertrophy
C1515655||in vivo
C0162772||reactive oxygen species
C0162772||(ROS
C0026237||mitochondrial
C0596235||Ca(2+)
C0038999||swelling
C1383860||cardiac hypertrophy
C0162416||Swiss mice
C0442120||intraperitoneally
C0022245||isoproterenol
C0012022||Diazoxide
C0764439||mitoKATP
C0098450||5-hydroxydecanoate
C0764439||mitoKATP
C0022245||Isoproterenol
C0025929||mice
C0018787||heart
C1279118||tibia
C0225828||myocyte
C0243095||cross-sectional areas
C0018787||hearts
C0020281||H2O2
C1151528||glutathione peroxidase activity
C0764439||mitoKATP
C1882151||opening
C0012022||diazoxide
C0022245||isoproterenol
C0098450||5-hydroxydecanoate
C0026237||mitochondria
C0022245||Isoproterenol
C0018787||hearts
C0596235||Ca(2+)
C0038999||swelling
C0908146||mitochondrial permeability transition pore
C1882151||opening
C0764439||MitokATP
C1882151||opening
C0596235||Ca(2+)
C0026244||mitochondrial swelling
C0098450||5-hydroxydecanoate
C0764439||mitoKATP
C1882151||opening
C0205160||negatively
C1327622||regulates
C1383860||cardiac hypertrophy
C1096176||mitochondrial damage